Cutaneous side-effects of EGFR inhibitors and their management.
about
Dermatologic toxicities in epidermal growth factor receptor and multikinase inhibitors.A review of the treatment options for skin rash induced by EGFR-targeted therapies: Evidence from randomized clinical trials and a meta-analysis.Acneiform rash during lung cancer therapy with erlotinib (Tarceva(®)).Extreme Phenotype of Epidermal Growth Factor Receptor Inhibitor-induced Destructive Folliculitis.Epidermal Growth Factor and Epidermal Growth Factor Receptor: The Yin and Yang in the Treatment of Cutaneous Wounds and Cancer.
P2860
Cutaneous side-effects of EGFR inhibitors and their management.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
Cutaneous side-effects of EGFR inhibitors and their management.
@ast
Cutaneous side-effects of EGFR inhibitors and their management.
@en
Cutaneous side-effects of EGFR inhibitors and their management.
@nl
type
label
Cutaneous side-effects of EGFR inhibitors and their management.
@ast
Cutaneous side-effects of EGFR inhibitors and their management.
@en
Cutaneous side-effects of EGFR inhibitors and their management.
@nl
prefLabel
Cutaneous side-effects of EGFR inhibitors and their management.
@ast
Cutaneous side-effects of EGFR inhibitors and their management.
@en
Cutaneous side-effects of EGFR inhibitors and their management.
@nl
P2093
P1433
P1476
Cutaneous side-effects of EGFR inhibitors and their management
@en
P2093
Wollenberg A
P577
2011-01-01T00:00:00Z